Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, you don't. You seem to have glossed over the minor fact that we have a NEW president with NEW connections. Paulson is NOT their only option when it comes to financing - not anymore.
I think what you're missing is there are other mab(s) out there that have shown to be superior to Lenzilumab, like CYDY's Leronlimab. Look at the results of their basket trial and P2 NASH results for example. That will make it an up-hill battle for Lenzilumab as it tries to survive a crushing blow this week. I'm not suggesting anyone sell their HGEN and buy CYDY, because as investors that's your decision, but at least you need to be aware of your options and try to keep the emotions out of your investment strategy.
No I didn't. Show me where I said the exact same thing.
And that is why they're not voting on the additional shares until the end of August. Got it!
WRONG! Can you PROVE with a FACTUAL proof that these catalysts are NOT going to occur?
Wow - talk about conspiracies! LMAO
It's hard to believe NP still lives in the heads of the failed gang of 13D miscreants.
Wrong! You're assuming the share price remains the same for the next year. NOT going to happen! There are too many catalysts on the horizon that will move this up over the next few months.
I have 200,000,000 shares? I think you're confused again.
Not from what we've been hearing for the last three years!
Glad to see that after six months some have moved on from NP being the problem to it now being our new President. So, you've come to the conclusion that the 6 month period is due to a precarious cash position even though we're voting to authorize another 350m shares in six weeks. LMAO! UFB!
Huh? You mean like a new President or finalizing the BLA or releasing the hold or a partnership? Please share your inside information that supports your "opinion" there are no big catalysts in the coming months. Waiting and laughing...
...and now it's down to .59
So, after cutting salaries across the board, who would you expect to still be there to execute your to-do list? Maybe hire some recent grad students at $150k/year?
Seriously?? An employment agreement is nothing more than a letter of "intent" to hire on a specific date under specific conditions. It is NOT the date he was hired. LMAO!!!
If you're referring to CYDY, I don't know who that is.
It's right in the PR in black and white.
"today announced the appointment of Dr. Cyrus Arman as President effective July 9, 2022."
CytoDyn Appoints Cyrus Arman, Ph.D., MBA, as President
https://www.cytodyn.com/newsroom/press-releases/detail/604/cytodyn-appoints-cyrus-arman-ph-d-mba-as-president
Please share the link showing 95% of all pre-revenue biotechs go bankrupt. Waiting and laughing.
"WRONG! This exact same pattern - more dilution, lower prices, less cash - is exactly the one followed by 95% of public companies that go to the graveyard"
WRONG! I said the exact opposite. Shorts understand that pre-revenue biotechs like CYDY rely on selling shares to fund their companies, and when they succeed, the shorts lose money.
So, you're saying the funding they're now asking for is even less than what I suggested and much less than their previous request. Thank you for making my point.
"ALSO, you are suggesting they issue these shares at the market price. The last "financing" was done at .25 per share. "
You're ignoring my point which was to compare the value of the shares at the time of the approvals. The funding they're requesting now is less than what they previously requested. It's just simple math that anyone can easily do to see the comparison.
When we authorized the current 200m shares, the pps was ~$1.10 which equated to over $200m. Assuming they get the additional 350m shares approved, it only equates to ~$140m (at the recent average of .40/share). Technically, they're asking for less than the previous request which leads me to believe they either think the price will be going up soon or that they won't need to self-fund much longer.
"Scott Kelly: Regarding the NASH, about how NASH attracted partnerships, we just presented the PDFF and cT1 and biomarker data at EASL in London, just to shed some color on the importance of the EASL meeting, there were over 7,000 delegates present or online from 114 countries. There were 1,722 abstracts presented. There were only 4 poster presentations selected for a walking tour with the chairman at EASL. And We were one of those 4. I was present and I can tell you, it was well received by the scientific community. We cannot comment on potential partnerships. But there are multiple opportunities for NASH and NASH HIV."
So, you're saying this was a waste of company funds???
Uh-oh... up 7% already. Looks like more panic buying! LMAO!!!
Yeah, sp is still green - looks like real panic mode. LMAO!!!
I called that number and got the panic hotline for CYDY shorts. Are you sure that's the correct number?
Complete BS - show proof of this. Waiting and laughing...
You think that's bad. Just look at all of the $m and diluted shares that Tony C squandered on his buddy Pestell and ProstaGene that turned out to be nothing more than a boondoggle.
"“Richard is a driving force in CCR5 antagonist research and we gain significant expertise and intellectual property with this acquisition that advances the development of PRO 140 as a novel cancer metastasis therapeutic,” said Anthony D. Caracciolo, CytoDyn’s Chairman. “We are privileged to have Richard join CytoDyn to expand our executive and scientific team, and we enthusiastically welcome him as the newest member of our board of directors.”
https://www.globenewswire.com/news-release/2018/11/19/1653508/0/en/CytoDyn-Completes-Acquisition-of-ProstaGene-and-Names-Dr-Richard-G-Pestell-to-Board-of-Directors.html
So, you have inside information about there being no partnerships. Please share.
So, this "POS" is why you "still have some shares"? LMAO!!!
The shorts still love NP but unfortunately for them, he's no longer there, so it's getting really old.
It's well understood and being swept under the carpet.
LOL If you think that's funny, he's still haunting the shorts 6 months after being gone and replaced. LMAO!!!
Complete bogus BS! There's absolutely NO proof to this fairy tale from 30 years ago. Ibox laughable...
Due to inflation, I hear that some of the shorts are now trying to charge NP instead of continuing to allow him to live rent-free in their heads.
Please show where the last week stock awards were in lieu of cash salary.
WRONG AGAIN!
"Conclusions: The primary endpoint (PDFF) and secondary endpoints (cT1) were met for the 350 mg group and moderate to severe fibro-inflammation by cT1 350 mg subgroup at baseline. The pooled 350 + 700 mg group also had significant reductions in PDFF, cT1 vs placebo. Treatment with leronlimab was well tolerated. These results are supportive of further trials with leronlimab for NASH."
Can you spell "PARTNERSHIP"?
NWBO is down 20% today? Not as bad as the recent 60% blood bath. Looks like I dodged another bullet! LMAO
Nope! Buying NWBO would be too Polarizing and Akin to throwing good money after bad. I'll wait until it hits .30.
Have a GREAT Friday!
Wrong, Wrong, and Wrong! Please feel free to provide a link to this.
Vyera was back in 2019 and for HIV. What does that have to do with a pending partnership for NASH and mTNBC???